Medtronic PLC

MDT

Equity

ISIN IE00BTN1Y115 / Valor 25187155

New York Stock Exchange, Inc (2025-11-21)

USD 101.20+1.86%

Medtronic PLC
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Medtronic PLC is a global leader in healthcare technology, focusing on the development and innovation of medical solutions to address some of the world's most complex and challenging health conditions. With a commitment to improving lives, the company leverages data, artificial intelligence, and an in-depth understanding of the human body to create groundbreaking technologies. Medtronic's portfolio includes a wide range of products and therapies designed to alleviate pain, restore health, and extend life, impacting patients across various medical fields. The company's approach to innovation emphasizes less-invasive surgical techniques, the development of compact medical devices such as the smallest pacemaker, and the advancement of robotic-assisted surgery to enhance precision and predictability in medical procedures. Medtronic's mission is driven by a focus on compassionate care, aiming to transform two lives per second through technologies that integrate seamlessly into patients' lifestyles and improve clinical, economic, and societal outcomes worldwide.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Medtronic achieved Q1 worldwide revenue of $8.578 billion, an increase of 8.4% as reported and 4.8% on an organic basis, driven by the success of key product segments including Pulsed Field Ablation, Transcatheter Valves, Neuromodulation, Diabetes, and Leadless Pacing.

Financial Performance

GAAP operating profit reached $1.445 billion with a 16.8% margin, while non-GAAP operating profit was $2.016 billion and non-GAAP diluted EPS was $1.26, reflecting a 2% increase.

Guidance Update

The company reiterated its FY26 revenue growth guidance of approximately 5% organic growth and raised its diluted non-GAAP EPS guidance to $5.60 to $5.66, up from the previous range of $5.50 to $5.60, due to improved tariff impact assumptions.

Summarized from source with an LLMView Source

Key figures

19.4%1Y

23.0%3Y

-8.13%5Y

Performance

21.8%1Y

21.3%3Y

22.1%5Y

Volatility